Posts tagged Teva
Teva weighs the most in eight weeks versus U. S. Court reverse the decision on patents
0Teva Falls Most in 8 Weeks as U.S. Court Refuses to Overturn Patent Ruling
Teva Pharmaceutical Industries Ltd. declined the most in almost eight weeks after a U.S. Court denied a motion by the world’s largest maker of generic drugs to overturn a jury verdict on the validity of a Wyeth patent.
Read more on Bloomberg
Astra Zeneca grants Teva generic Crohn’s Drug License
0AstraZeneca grants Teva generic Crohn’s drug license
LONDON (SHARECAST) – AstraZeneca has signed a deal with Teva Pharmaceuticals USA to settle patent litigation regarding Teva’s proposed generic version of Astra’s Entocort EC (budesonide) capsules used to treat Crohn’s disease.
Read more on ShareCast
Pfizer’s Wyeth wins trial over Teva copy of Protonix
0Pfizer’s Wyeth wins trial over Teva copy of Protonix
WASHINGTON: Pfizer Inc’s Wyeth unit and Altana AG won a jury verdict on the validity of their patent for the heartburn drug Protonix, according to agencies report.
Read more on The Hindu
Teva expected to lose patent infringement suit to Pfizer
0Teva expected to lose patent infringement suit to Pfizer
Teva Pharmaceutical’s business strategy in the United States is based largely on selling generic versions of blockbuster drugs even though the company is liable to lose patent infringement suits filed subsequently by the makers of the propriety versions.
Read more on Haaretz Daily
Teva shares fall after losing Protonix patent case
0Teva shares fall after losing Protonix patent case
* Teva shares fall after Protonix patent ruling
Read more on Reuters via Yahoo! Philippines News
Pfizer wins Protonix patent case vs Teva
0Pfizer wins Protonix patent case vs Teva
* Jury finds Protonix patent infringed by Teva
Read more on Reuters via Yahoo! Singapore News
Company Profile: Teva
0Company Profile: Teva
As of 8:10 PM 04/16/10 All times are local (Market data is delayed by at least 15 minutes). Indexes reversed earlier losses after a big sell-off in Shanghai.
Read more on BusinessWeek